(Alliance News) - Creo Medical Group PLC on Wednesday said the Royal Oldham hospital in Greater Manchester has now treated over 40 patients with two of Creo Medical's technologies. Read More
(Alliance News) - Creo Medical PLC said it expects to report a boost in revenue and a decrease in its administrative expenses in its half year. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Creo Medical Group PLC on Monday said the first upper gastrointestinal tract using the Speedboat Inject procedure has been completed in Europe since its clearance last week. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More
(Alliance News) - Stocks in London ended lower on Monday, weighed down by a disappointing post-Covid recovery in China and the increasing expectation that interest rates in the UK will keep pushing higher. Read More
Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Says its Speedboat Inject endoscopy product has been cleared for use in the entire gastrointestinal tract within European markets. Speedboat Inject is already cleared for full use in the gastrointestinal tract for the cutting and coagulation of soft tissue using radio frequency and microwave energy in the US and Asia Pacific regions. It is used for the prevention and treatment of bowel cancer. Adds it already has a "healthy pipeline" of clinicians ready to use the Speedboat Inject device for upper gastrointestinal procedures across Europe, with demonstrations, training and procedures already planned. Read More
(Alliance News) - Creo Medical Group PLC on Thursday said the National Institute for Health & Care Excellence in the UK has selected its Speedboat Inject product for assessment. Read More
(Alliance News) - Creo Medical Group PLC on Tuesday said that it has reached its first in-human milestone for MicroBlate Flex, as part of a Lung Tissue ablation clinical study. Read More
Creo Medical Group PLC - Chepstow, Wales-based medical device company specialising in surgical endoscopy - Reports Royal Oldham Hospital has become latest NHS England hospital to utilise Speedboat Inject endoscopy device to prevent and treat bowel cancer. The hospital has also taken delivery of multiple CROMA Advanced Energy platform endoscope products and put in place weekly lists for multiple Speedboat Submucosal Dissection equipment. Read More
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on the field of surgical endoscopy - Updates on its earn-out agreement related to the acquisition of Albyn Medical SL, now known as Creo Medical SL. Read More
Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Proposes to raise up to GBP5.2 million through an open offer, allowing qualifying shareholders to subscribe to 26.0 million shares at a price of 20 pence per share. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Creo Medical Group PLC on Thursday proposed a placing and subscription of new shares to raise a minimum of GBP25.0 million, alongside a GBP5.2 million open offer. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More
(Alliance News) - Creo Medical Group PLC on Wednesday said sales of its core electrosurgical products and technology multiplied nearly eight times in 2022 from the year before. Read More
(Alliance News) - Creo Medical Group PLC on Monday said it had signed an intellectual property licence and a royalty agreement with CMR Surgical Ltd. Read More